Sodium orthovanadate

Key Product Details

Product Description

Sodium orthovanadate is an inhibitor of protein tyrosine phosphatases, alkaline phosphatases and ATPases. Suppresses p53-mediated apoptosis by transcription-dependent and -independent pathways.

Product Specifications for Sodium orthovanadate

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Solubility

Preparing Stock Solutions for Sodium orthovanadate

The following data is based on the product molecular weight 183.91.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:

1 Recalculate

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	5.44 mL	27.19 mL	54.37 mL
5 mM	1.09 mL	5.44 mL	10.87 mL
10 mM	0.54 mL	2.72 mL	5.44 mL
50 mM	0.11 mL	0.54 mL	1.09 mL

Calculators

Background References

References are publications that support the biological activity of the product. See our Citations tab to view 9 publications citing the usage of this product.

• Morita Sodium orthovanadate inhibits p53-mediated apoptosis. Cancer Res. 2010 PMID: 20048077
• Hasegawa Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats. J.Pharmacol.Exp.Ther. 2006 PMID: 16461588
• Matsumoto Sodium orthovanadate enhances proliferation of progenitor cells in the adult rat subventricular zone after focal cerebral ischemia. J.Pharmacol.Exp.Ther. 2006 PMID: 16782823
• Ai Inhibition of small-intestinal sugar absorption mediated by sodium orthovanadate Na₃VO₄ in rats and its mechanisms. World J.Gastroenterol. 2004 PMID: 15534916

Product Documents for Sodium orthovanadate